对AVF血栓的早期皮肤穿血栓溶解:症状持续时间作为内血管救援预测的指标
Ismail Taskent1, Guler Gulsen Ersoy2
1Department of Radiology, Faculty of Medicine, Kastamonu University, Kastamonu, Türkiye. dr.taskent@gmail.com.
CVIR endovascular
|August 19, 2025
概括
通过皮肤进行的血栓缓解疗法有效地治疗血液透析患者的急性动脉静脉囊血栓症. 早期干预至关重要,因为症状持续时间超过2.5天可以预测需要进一步的内血管治疗.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血管外科 血管外科
- 干预性放射学 干预性放射学
背景情况:
- 动脉静脉 (AVF) 血栓形成是血液透析 (HD) 患者的主要并发症,往往需要紧急干预.
- 透皮血栓解压疗法 (PTT) 为恢复AVF通透性提供了对内血管治疗 (EVT) 的更少侵入性的替代方案.
研究的目的:
- 为了评估超声波引导的PTT与低剂量阿尔特普拉斯对急性AVF血栓形成的有效性.
- 为了确定PTT后后续EVT要求的预测因素.
主要方法:
- 对42名接受超声导向PTT治疗的HD患者 (3-5毫克Alteplase) 的回顾性分析.
- 评估技术/临床成功,并发症和需要额外的EVT.
- 后勤回归和ROC分析以确定EVT的预测因素.
主要成果:
- 临床成功率高 (97.6%),其中69%的患者在没有EVT的情况下获得了通透性.
- 症状持续时间>2.5天是EVT最强的预测因素 (p=0.01).
- 每增加一个症状日,EVT的几率增加了88.5% (OR=1.885,p=0.012);女性患者的EVT率也更高 (p=0.005).
结论:
- 皮肤穿透性血栓解压疗法是一种高度有效的,对急性AVF血栓形成的微创性治疗方法.
- 症状持续时间超过2.5天是预测需要EVT的关键值.
- 早期干预对于优化通道救援和透析患者的结果至关重要.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
01:25Hemodialysis I: Introduction
287
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
287
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34